Recent article about stromal vascular fraction research -- $USRM stock worth 2 cents, but not because of Dr. Vic!
Published By Kristin Comella, USRM Chief Science Officer
Effects of the intramyocardial implantation of stromal vascular fraction in patients with chronic ischemic cardiomyopathy CSO Kristin Comella Publishes Paper on the Implantation of Stromal Vascular Fraction in Patients with Cardiomyopathy
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.